Syndax Pharmaceuticals (SNDX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to $86.9 million.
- Syndax Pharmaceuticals' Shares Outstanding rose 189.93% to $86.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.9 million, marking a year-over-year increase of 189.93%. This contributed to the annual value of $85.7 million for FY2024, which is 102.3% up from last year.
- Syndax Pharmaceuticals' Shares Outstanding amounted to $86.9 million in Q3 2025, which was up 189.93% from $86.1 million recorded in Q2 2025.
- Syndax Pharmaceuticals' 5-year Shares Outstanding high stood at $86.9 million for Q3 2025, and its period low was $48.2 million during Q1 2021.
- For the 5-year period, Syndax Pharmaceuticals' Shares Outstanding averaged around $70.1 million, with its median value being $69.4 million (2023).
- In the last 5 years, Syndax Pharmaceuticals' Shares Outstanding surged by 5954.77% in 2021 and then skyrocketed by 102.3% in 2024.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Shares Outstanding stood at $55.0 million in 2021, then rose by 23.88% to $68.1 million in 2022, then increased by 24.54% to $84.8 million in 2023, then grew by 1.02% to $85.7 million in 2024, then rose by 1.41% to $86.9 million in 2025.
- Its Shares Outstanding stands at $86.9 million for Q3 2025, versus $86.1 million for Q2 2025 and $86.0 million for Q1 2025.